NCT06723457
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
Clinical trial condition
Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder
Explore clinical trials studying Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
Recurrent Polymorphic Post-Transplant Lymphoproliferative Disorder trial results
NCT06672705
- Conditions
- Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder, EBV-Related Post-Transplant Lymphoproliferative Disorder, Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder, +3 more
- Locations
-
- Washington University St Louis, Missouri, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT02900976
- Conditions
- EBV-Related Post-Transplant Lymphoproliferative Disorder, Monomorphic Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder, +4 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Loma Linda University Medical Center Loma Linda, California, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
Related conditions
- EBV-Related Post-Transplant Lymphoproliferative Disorder (2)
- Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder (2)
- Refractory Monomorphic Post-Transplant Lymphoproliferative Disorder (2)
- Refractory Polymorphic Post-Transplant Lymphoproliferative Disorder (2)
- Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder (1)
- Hemic and Lymphatic Diseases (1)
- Immune System Diseases (1)
- Immunoproliferative Disorders (1)